Due to the COVID-19 crisis, the information below is subject to change,
in particular that concerning the teaching mode (presential, distance or in a comodal or hybrid format).
3 credits
30.0 h + 15.0 h
Q2
Teacher(s)
Bindels Laure; Frédérick Raphaël; Henrard Séverine; Jacqmin Philippe; Leclercq Joëlle; Van Bambeke Françoise (coordinator);
Language
French
Main themes
- Definition of drug targets in the context of physiopathology and in a economical and societal perspective
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
Aims
At the end of this learning unit, the student is able to : | |
| 1 |
Analysis and understanding of the successive steps leading to the discovery, the preclinical and clinical development, and the commercialization of drugs. Knowledge of the process for integrating it in professional activities |
Content
2h sessions centered on one specific aspect, with description and analysis of the considered aspects and examples taken from drug development history.
Evaluation methods
Due to the COVID-19 crisis, the information in this section is particularly likely to change.
- Written examination with open questions (discussion starting from practical examples)- Individual work, aiming at proposing the development plan of a fictive drug
Faculty or entity
FARM
